Global Ganja Report

Advocates increasingly assert that cannabis legalization is not fully realized unless workers are guaranteed their right to employment even if they partake of the herb off-hours. Some states are finally taking measures to rein in the use of urine-test results as an excuse to fire or turn down job applicants.

Driven by the notorious market glut in Oregon, wholesale cannabis prices have predictably plunged in the Beaver State. They have done so less precipitously in other western states. But this is offset by continued high prices elsewhere in the country, especially the East Coast—making for an overall upward trend this year.

The prosecutor for Miami-Dade County is the latest of several around the country to halt minor cannabis cases. The move was prompted by a dilemma vexing law enforcement nationwide: the inability to distinguish between THC and legal CBD in confiscated samples.

Things have moved slowly in authoritarian Thailand since passage of a medical marijuana law last year. But now one of the country's leading universities is launching a "Ganja Studies Department," and attendant research facility. With plans to train a new generation of cultivators and entrepreneurs, the crafters of the program are voicing aspirations to make Thailand Asia's cannabis leader.

Activists in North Dakota are heartened by the state's recent reduction of cannabis penalties, but insist that (contrary to media reports) it is not true decriminalization. And they are gearing up a new effort to get a legalization initiative approved in next year's elections.

With industry waiting on the FDA to issue regs for CBD products, the agency instead released a statement explaining why it has not yet done so—including fears that the trendy cannabinoid may cause liver damage. But advocates charge that the claim is based on faulty research.

The arrival of 7-10 as a special day to celebrate extracts and concentrates marks the growing embrace of "dabbing" by the cannabis community. But the laws governing such products and especially their production vary from state to state. And the real risks continue to garner grim headlines that cast the cannabis industry in a very poor light.

Building on longstanding policy that bars federal cannabis enforcement in medical marijuana states, the House of Representatives passed a measure that would instate a similar hands-off approach to enforcement in states that have generally legalized. Other measures would slash funding for the DEA, and call upon the FDA to promulgate regs for CBD.